New partnership to prioritise mesothelioma treatment uncertainties
Today is the launch of an important
‘Priority Setting Partnership’ (PSP) set up by the James Lind Alliance (JLA) to
identify and prioritise unanswered questions about mesothelioma
treatments.
Mesothelioma is a rare and often fatal form
of cancer with very poor survival rates. It is most commonly caused by
breathing in asbestos dust. Mesothelioma usually...
Source: NIHR Evaluation, Trials and Studies News - Category: American Health Source Type: news
More News: American Health | Asbestosis | Cancer | Cancer & Oncology | Mesothelioma | National Institute for Health Research (NIHR) | Partnerships | Study